Home   »  TRADE TOPICS  »  Prescription Drugs  »  Reimportation of prescription drugs

Drug Reimportation: The Free Market Solution

This CATO Institute Policy Analysis argues that allowing reimportation would undermine the ability of pharmaceutical firms to charge different prices in similar countries - resulting in lower prices in the US, but higher prices in Europe and Canada. 

Unless otherwise expressly stated, all original material of whatever nature created by the Forum on Democracy & Trade website is licensed under a Creative Commons License. Privacy Statement | Sitemap